Conduit Pharmaceuticals Inc
NASDAQ:CDT
Balance Sheet
Balance Sheet Decomposition
Conduit Pharmaceuticals Inc
Conduit Pharmaceuticals Inc
Balance Sheet
Conduit Pharmaceuticals Inc
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
0
|
0
|
4
|
1
|
|
| Cash |
0
|
0
|
4
|
1
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
2
|
2
|
|
| Total Current Assets |
0
|
0
|
6
|
3
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
1
|
|
| Total Assets |
0
N/A
|
0
N/A
|
7
+144 380%
|
4
-42%
|
|
| Liabilities | |||||
| Accounts Payable |
0
|
0
|
0
|
1
|
|
| Accrued Liabilities |
2
|
3
|
1
|
2
|
|
| Short-Term Debt |
0
|
0
|
1
|
7
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
0
|
0
|
|
| Total Current Liabilities |
2
|
4
|
2
|
11
|
|
| Long-Term Debt |
1
|
2
|
0
|
0
|
|
| Other Liabilities |
3
|
4
|
6
|
0
|
|
| Total Liabilities |
6
N/A
|
10
+70%
|
8
-24%
|
11
+43%
|
|
| Equity | |||||
| Common Stock |
0
|
0
|
0
|
0
|
|
| Retained Earnings |
6
|
11
|
11
|
29
|
|
| Additional Paid In Capital |
0
|
0
|
10
|
22
|
|
| Other Equity |
0
|
1
|
0
|
0
|
|
| Total Equity |
6
N/A
|
10
-70%
|
0
+95%
|
7
-1 386%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
7
+144 380%
|
4
-42%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
1
|
1
|
74
|
0
|
|